Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shezhi Shenhuang Ointment is a topical Traditional Chinese Medicine (TCM) formulation developed and manufactured by Guangdong Pibao Pharmaceutical. It is primarily indicated for the treatment of eczema, specifically the 'damp-heat accumulating in the skin' (湿热蕴肤) syndrome, and superficial fungal infections. The ointment's composition leverages the therapeutic properties of snake fat (Shezhi) alongside herbal extracts such as Ginseng and Scutellaria baicalensis, which collectively provide anti-inflammatory, antipruritic, and antifungal effects. It is an approved pharmaceutical product in China (NMPA approval 国药准字Z20025071) and has been the subject of post-marketing clinical trials to evaluate its safety and efficacy under widespread usage conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shezhi shenhuang ointment.